The Most Transformative FDA Approvals of 2025 | Cromos Pharma
The Most Transformative FDA Approvals of 2025: Therapies Redefining Clinical Research and Future Trial Strategy FDA approvals have always reflected scientific progress, but the 2025 roster does more than showcase innovation — it captures the rapidly changing nature of clinical trials themselves. This year’s approvals highlight how development programs are becoming more precise, more data-driven, and more tightly aligned with molecular insights that reshape traditional trial models. Across oncology, hematology, Read more
Infectious Disease CRO
Infectious Disease CRO: Expertise, Services, and Capabilities for Clinical Trials Infectious diseases remain one of the most challenging areas in clinical development. Driven by rapidly evolving pathogens, emerging outbreaks, rising antimicrobial resistance, and the global burden of viral and bacterial infections, drug and vaccine developers increasingly rely on specialized Clinical Research Organizations (CROs) to accelerate clinical trials, ensure compliance, and deliver high-quality data. This article Read more
Clinical Research Focus. 47th Edition Clinical Research Focus featuring topical articles of interest to the clinical trial community. Explore the news of December 2025. Read more
Cancer Vaccines 2025, Part II: The Rise of DNA Cancer Vaccines | Cromos Pharma
Cancer Vaccines 2025, Part II: The Rise of DNA Cancer Vaccines Cancer vaccines are entering a new era — and it’s no longer just about mRNA. A powerful second wave is gaining momentum: DNA cancer vaccines. Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us